Regulation of proteasomes in prion disease

Acta Biochimica et Biophysica Sinica

Volumn 46, Issue 7, 2014, Pages 531-539

  Zhu, Ting ^a   Hayat Khan, Sher ^a   Zhao, Deming ^a   Yang, Lifeng ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

autophagy; neurodegenerative disease; prion disease; proteasome

Indexed keywords

PROTEASOME; UBIQUITIN;

AUTOPHAGY; DEGENERATIVE DISEASE; ENZYMOLOGY; HUMAN; IMMUNOLOGY; METABOLISM; PRION DISEASE;

AUTOPHAGY; HUMANS; NEURODEGENERATIVE DISEASES; PRION DISEASES; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITIN;

EID: 84903714203     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmu031     Document Type: Review

References (100)

1. Harris DA and True HL. New insights into prion structure and toxicity. Neuron 2006, 50: 353-357.
2. Hu PP and Huang CZ. Prion protein: structural features and related toxicity. Acta Biochim Biophys Sin 2013, 45: 435-441.
3. Hershko A and Ciechanove r A. The ubiquitin system. Annu Rev Biochem 1998, 67: 425-479.
4. Ciechanover A and Brundin P. The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron 2003, 40: 427-446.
5. Ma J, Wollmann R and Lindquist S. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 2002, 298: 1781-1785.
6. Deriziotis P, Andre R, Smith DM, Goold R, Kinghorn KJ, Kristiansen M and Nathan JA, et al. Misfolded PrP impairs the UPS by interaction with the 20S proteasome and inhibition of substrate entry. EMBO J 2011, 30: 3065-3077.
7. Mastrianni JA. Prion diseases. Clin Neurosci Res 2004, 3: 469-480.
8. Kang SC, Brown DR, Whiteman M, Li R, Pan T, Perry G and Wisniewski T, et al. Prion protein is ubiquitinated after developing protease resistance in the brains of scrapie-infected mice. J Pathol 2004, 203: 603-608.
9. Milhavet O, McMahon HE, Rachidi W, Nishida N, Katamine S, Mange A and Arlotto M, et al. Prion infection impairs the cellular response to oxidative stress. Proc Natl Acad Sci USA 2000, 97: 13937-13942.
10. Willia ms A, Lucassen PJ, Ritchie D and Bruce M. PrP deposition, microglial activation, and neuronal apoptosis in murine scrapie. Exp Neurol 1997, 144: 433-438.
11. Mallucc i GR, Ratte S, Asante EA, Linehan J, Gowland I, Jefferys JG and Collinge J. Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J 2002, 21: 202-210.
12. Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M and Weissmann C. Mice devoid of PrP are resistant to scrapie. Cell 1993, 73: 1339-1347.
13. Griffith JS. Self-replication and scrapie. Nature 1967, 215:1043-1044.
14. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982, 216: 136-144.
15. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998, 95: 13363-13383.
16. Zhou Z and Xiao G. Conformational conversion of prion protein in prion diseases. Acta Biochim Biophys Sin 2013, 45: 465-476.
17. Yuan Z, Zhao D and Yang L. Decipher the mechanisms of rabbit 's low susceptibility to prion infection. Acta Biochim Biophys Sin 2013, 45: 899-903.
18. Legname G, Baskakov IV, Nguyen HO, Riesner D, Cohen FE, DeArmond SJ and Prusiner SB. Synthetic mammalian prions. Science 2004, 305: 673-676.
19. Castilla J, Saa P, Hetz C and Soto C. In vitro generation of infectious scrapie prions. Cell 2005, 121: 195-206.
20. Deleault NR, Harris BT, Rees JR and Supattapone S. Formation of native prions from minimal components in vitro. Proc Natl Acad Sci USA 2007, 104: 9741-9746.
21. Wang F, Wang X, Yuan CG and Ma J. Generating a prion with bacterially expressed recombinant prion protein. Science 2010, 327: 1132-1135.
22. Lansbury PT, Jr and Caughey B. The chemistry of scrapie infection: implications of the ice 9 metaphor. Chem Biol 1995, 2: 1-5.
23. Saborio GP, Permanne B and Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001, 411: 810-813.
24. Soto C. Transmissible proteins: expanding the prion heresy. Cell 2012, 149: 968-977.
25. Peters JM, Franke WW and Kleinschmidt JA. Distinct 19S and 20S subcomplexes of the 26S proteasome and their distribution in the nucleus and the cytoplasm. J Biol Chem 1994, 269: 7709-7718.
26. Lodish HBA, Matsudaira P, Kaiser CA, Krieger M, Scott MP, Zipursky SL and Darnell J. Molecular Cell Biology (5th end). New York: WH Freeman and CO, 2004: 66-72.
27. Baumeister W, Walz J, Zuhl F and Seemuller E. The proteasome: paradigm of a self-compartmentalizing protease. Cell 1998, 92: 367-380.
28. Fruh K, Gossen M, Wang K, Bujard H, Peterson PA and Yang Y. Displacement of housekeeping proteasome subunits by MHC-encoded LMPs: a newly discovered mechanism for modulat ing the multicatalytic proteinase complex. EMBO J 1994, 13: 3236-3244.
29. Deriziotis P and Tabrizi SJ. Prions and the proteasome. Biochim Biophys Acta 2008, 1782: 713-722.
30. Jung T and Grune T. Structure of the proteasome. Prog Mol Biol Transl Sci 2012, 109: 1-39.
31. Coux O, Tanaka K and Goldberg AL. Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 1996, 65: 801-847.
32. Voges D, Zwickl P and Baumeister W. The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu Rev Biochem 1999, 68: 1015-1068.
33. Pickering AM, Koop AL, Teoh CY, Ermak G, Grune T and Davies KJ. The immunoproteasome, the 20S proteasome and the PA28alphabeta proteasome regulator are oxidative-stress-adaptive proteolytic complexes. Biochem J 2010, 432: 585-594.
34. Murata S, Udono H, Tanahashi N, Hamada N, Watanabe K, Adachi K and Yamano T, et al. Immunoproteasome assembly and antigen presentation in mice lacking both PA28alpha and PA28beta. EMBO J 2001, 20: 5898-5907.
35. Bence NF,Sampat RM,Kopito RR. Impairment of the ubiquitinproteasome system by protein aggregation. Science 2001, 292:1552-1555.
36. Ciechano ver A, Orian A and Schwartz AL. Ubiquitin-mediated proteolysis: biological regulation via destruction. Bioessays 2000, 22: 442-451.
37. Pickart CM. Ubiquitin in chains. Trends Biochem Sci 2000, 25: 544-548.
38. McNaught KS, Olanow CW, Halliwell B, Isacson O and Jenner P. Failure of the ubiquitin-proteasome system in Parkinson's disease. Nat Rev Neurosci 2001, 2: 589-594.
39. Glickman MH, Rubin DM, Coux O, Wefes I, Pfeifer G, Cjeka Z and Baumeister W, et al. A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and re lated to the COP9-signalosome and eIF3. Cell 1998, 94: 615-623.
40. Liu CW and Jacobson AD. Functions of the 19S complex in proteasomal degradation. Trends Biochem Sci 2013, 38: 103-110.
41. Lander GC, Estrin E, Matyskiela ME, Bashore C, Nogales E and Martin A. Complete subunit architecture of the proteasome regulatory particle. Nature 2012, 482: 186-191.
42. Smith DM, Chang SC, Park S, Finley D, Cheng Y and Goldberg AL. Docking of the proteasomal ATPases carboxyl termini in the 20S proteasome's alpha ring opens the gate for substrate entry. Mol Cell 2007, 27: 731-744.
43. Rabl J, Smith DM, Yu Y, Chang SC, Goldberg AL and Cheng Y. Mechanism of gate opening in the 20S proteasome by the proteasomal ATPases. Mol Cell 2008, 30: 360-368.
44. Smith DM, Kafri G, Cheng Y, Ng D, Walz T and Goldberg AL. ATP binding to PAN or the 26S ATPases causes association with the 20S proteasome, gate opening, and translocation of unfolded proteins. Mo l Cell 2005, 20: 687-698.
45. Kaneko T, Hamazaki J, Iemura S, Sasaki K, Furuyama K, Natsume T and Tanaka K, et al. Assembly pathway of the Mammalian proteasome base subcomplex is media ted by multiple specific chaperones. Cell 2009, 137: 914-925.
46. Kim BY, Olzmann JA, Barsh GS, Chin LS and Li L. Spongiform neurodegeneration-associated E3 ligase Mahogunin ubiquitylates TSG 101 and regulates endosomal trafficking. Mol Biol Cell 2007, 18: 1129-1142.
47. Lehman NL. The ubiquitin proteasome system in neuropathology. Acta Neuropathol 2009, 118: 329-347.
48. Lloyd SE, Maytham EG, Pota H, Grizenkova J, Molou E, Uphill J and Hummerich H, et al. HECTD2 is associated with susceptibility to mouse and human prion disease. PLoS Genet 2009, 5: e1000383.
49. Cohen E and Taraboulos A. Scrapie-like prion protein accumulates in aggresomes of cyclosporin A-treated cells. EMBO J 2003, 22: 404-417.
50. Mishra RS, Bose S, Gu Y, Li R and Singh N. Aggresome formation by mutant prion proteins: the unfolding role of proteasomes in familial prion disorders. J Alzheimers Dis 2003, 5: 15-23.
51. Kristiansen M, Messenger MJ, Klohn PC, Brandner S, Wadsworth JD, Collinge J and Tabrizi SJ. Disease-related prion protein forms aggresomes in neuronal cells leading to caspase activation and apoptosis. J Biol Chem 2005, 280: 38851-38861.
52. Jeffrey N, Keller KB and William R. Impaired proteasome function in Alzheimer 's disease. J Neurochem 2000, 75: 436-439.
53. Kristiansen M, Deriziotis P, Dimcheff DE, Jackson GS, Ovaa H, Naumann H and Clarke AR, et al. Disease-associated prion protein oligomers inhibit the 26S proteasome. Mol Cell 2007, 26: 175-188.
54. Forster A, Masters E, Whi tby F, Robinson H and Hill C. The 1.9 A structure of a proteasome-11S activator complex and implications for proteasome-PAN/PA700 interactions. Mol Cell 2005, 18: 589-599.
55. Whitby FG, Masters EI, Kramer L, Knowlton JR, Yao Y, Wang CC and Hill CP. Structural basis for the activation of 20S proteasomes by 11S regulators. Nature 2000, 408: 115-120.
56. Andre R,Tabrizi SJ. Misfolded PrP and a novel mechanism of proteasome inhibition. Prion 2012, 6:32-36.
57. Lilienbaum A. Relationship between the proteasomal system and autophagy. Int J Biochem Mol Biol 2013, 4: 1-26.
58. Shim SM, Lee WJ, Kim Y, Chang JW, Song S and Jung YK. Role of S5b/PSMD5 in proteasome inhibition caused by TNF-alpha/NFkappaB in higher eukaryotes. Cell Rep 2012, 2: 603-615.
59. Kim JI, Choi SI, Kim NH, Jin JK, Choi EK, Carp RI and Kim YS. Oxidative stress and neurodegeneration in prion diseases. Ann N Y Acad Sci 2001, 928: 182-186.
60. Perovic S, Schroder HC, Pergande G, Ushijima H and Muller WE. Effect of flupirtine on Bcl-2 and glutathione level in neuronal cells treated in vitro with the prion protein fragment (PrP106-126). Exp Neurol 1997, 147: 518-524.
61. White AR, Collins SJ, Maher F, Jobling MF, Stewart LR, Thyer JM and Beyreuther K, et al. Prion protein-deficient neurons reveal low er glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicity. Am J Pathol 1999, 155: 1723-1730.
62. Jung T and Grune T. The proteasome and its role in the degradation of o xidized proteins. IUBMB Life 2008, 60: 743-752.
63. Davies KJ. Degradation of oxidized proteins by the 20S proteasome. Biochimie 2001, 83: 301-310.
64. Breusing N and Grune T. Regulation of proteasome-mediated protein degradation during oxidative stress and aging. Biol Chem 2008, 389: 203-209.
65. Reinheckel T, Sitte N, Ullrich O, Kuckelkorn U, Davies KJ and Grune T. Comparative resistance of the 20S and 26S proteasome to oxidative stress. Biochem J 1998, 335: 637-642.
66. Shang F and Taylor A. Oxidative stress and recovery from oxidative stress are associated with altered ubiquitin conjugating and proteolytic activities in bovine lens epithelial cells. Biochem J 1995, 307: 297-303.
67. Wang X, Yen J, Kaiser P and Huang L. Regula tion of the 26S proteasome complex during oxidative stress. Sci Signal 2010, 3: 1-9.
68. Grune T, Catalgol B, Licht A, Ermak G, Pickering AM, Ngo JK and Davies KJ. HSP70 mediates dis sociation and reassociation of the 26S proteasome during adaptation to oxidative stress. Free Radic Biol Med 2011, 51: 1355-1364.
69. Klionsky DJ. Autophagy as a regulated pathway of cellular degradation. Science 2000, 290: 1717-1721.
70. Rubinsztein DC, DiFiglia M, Heintz N, Nixon RA, Qin ZH, Ravikumar B and Stefanis L, et al. Autophagy and its possible roles in nervous system dise ases, damage and repair. Autophagy 2005, 1: 11-22.
71. Heiseke A, Aguib Y and Schatzl HM. Autophagy, prion infection and their mutual interactions. Curr Issues Mol Biol 2010, 12: 87-97.
72. Boellaard JW, Kao M, Schlote W and Diringer H. Neuronal autophagy in experimental scrapie. Acta Neuropathol 1991, 82: 225-228.
73. Boellaard JW, Schlote W and Tateishi J. Neuronal autophagy in experimental Creutzfeldt-Jakob's disease. Acta Neuropathol 1989, 78: 410-418.
74. Schatzl HM LL, Holtzman DM, Tatzelt J, DeArmond SJ, Weiner RI, Mobley WC and Mobley WC, et al. A hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis. J Virol 1997, 71: 8821-8831.
75. Xu Y, Tian C, Wang SB, Xie WL, Guo Y, Zhang J and Shi Q, et al. Activation of the macroautophagic system in scrapie-infected experimental animals and human genetic prion diseases. Autophagy 2012, 8: 1604-1620.
76. Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, Tanida I and Ueno T, et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 2006, 441: 880-884.
77. Simonsen A,Cumming RC,Brech A,Isakson P,Schubert DR,Finley KD. Promoting basal levels of autophagy in the nervous system enhances longevity and oxidant resistance in adult Drosophila. Autophagy 2008, 4:176-184.
78. Nedelsky NB, Todd PK and Taylor JP. Autophagy and the ubiquitinproteasome system: collaborators in neuroprotection. Biochim Biophys Acta 2008, 1782: 691-699.
79. Yun SW, Ertmer A, Flechsig E, Gilch S, Riederer P, Gerlach M and Scha tzl HM, et al. The tyrosine kinase inhibitor imatinib mesylate delays prion neuroinvasion by inhibiting prion propagation in the periphery. J Neurovirol 2007, 13: 328-337.
80. Heiseke A, Aguib Y, Riemer C, Baier M and Schatzl HM. Lithium induces clearance of protease resistant prion protein in prion-infected cells by induction of autophagy. J Neurochem 2009, 109: 25-34.
81. Aguib Y, Heis eke A, Gilch S, Riemer C, Baier M, Schatzl HM and Ertmer A. Autophagy induction by trehalose counteracts cellular prion infection. Autophagy 2009, 5: 361-369.
82. Yao H, Zhao D, K han SH and Yang L. Role of autophagy in prion protein-induced neurodegenerative diseases. Acta Biochim Biophys Sin 2013, 45: 494-502.
83. Ding WX, Ni HM, Gao W, Yoshimori T, Stolz DB, Ron D and Yin XM. Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability. Am J Pathol 2007, 171: 513-524.
84. Johnston JA ,Ward CL and Kopito RR. Aggresomes: a cellular response to misfolded proteins. J Cell Biol 1998, 143: 1883-1898.
85. Korolchuk VI, Mansilla A, Menzies FM and Rubinsztein DC. Autophagy inhibition compromises degradation of ubiquitin-proteasome pathway substrates. Mol Cell 2009, 33: 517-527.
86. Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R and Yo koyama M, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 2006, 441: 885-889.
87. Lenk SE, Dunn WA, Jr, Trausch JS, Ciechanover A and Schwartz AL. Ubiquitin-activating enzyme, E1, is associated with maturation of autophagic vacuoles. J Cell Biol 1992, 118: 301-308.
88. Pandey UB, Nie Z, Batlevi Y, McCray BA, Ritson GP, Nedelsky NB and Schwartz SL, et al. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 2007, 447: 859-863.
89. Cecarini V, Bonfili L, Cuccioloni M, Mozzicafreddo M, Rossi G, Buizza L and Uberti D, et al. Crosstalk between the ubiquitin-proteasome system and autophagy in a human cellular model of Alzheimer's disea se. Biochim Biophys Acta 2012, 1822: 1741-1751.
90. Boyault C, Gilquin B, Zhang Y, Rybin V, Garman E, Meyer-Klaucke W and Matthias P, et al. HDAC6-p97/VCP controlled polyubiquitin chain turnover. EMBO J 2006, 25: 3357-3366.
91. Zhang L, Sheng S and Qin C. The role of HDAC6 in Alzheimer's disease. J Alzheimers Dis 2013, 33: 283-295.
92. Kirkin V, Lamark T, Sou YS, Bjorkoy G, Nunn JL, Bruun JA and Shvets E, et al. A role for NBR1 in autophagosomal degradation of ubiquitinated substrates. Mol Cell 2009, 33: 505-516.
93. . Komatsu M, Waguri S, Koike M, Sou YS, Ueno T, Hara T and Mizushima N, et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 2007, 131: 1149-1163.
94. Kuusisto E, Suuronen T and Salminen A. Ubiquitin-binding protein p62 expression is induced during apoptosis and proteasomal inhibition in neuronal cells. Biochem Biophys Res Commun 2001, 280: 223-228.
95. Nagaoka U, Kim K, Jana NR, Doi H, Maruyama M, Mitsui K and Oyama F, et al. Increased expression of p62 in expanded polyglutamine-expressing cells and its association with polyglutami ne inclusions. J Neurochem 2004, 91: 57-68.
96. Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H and vervatn A, et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degr adation of ubiquitinated protein aggregates by autophagy. J Biol Chem 2007, 282: 24131-24145.
97. Kaniuk NA, Kiraly M, Bates H, Vranic M, Volchuk A and Brumell JH. Ubiquitinated-protein a ggregates form in pancreatic beta-cells during diabetesinduced oxidative stress and are regulated by autophagy. Diabetes 2007, 56: 930-939.
98. Lamark T and Johansen T. Autophagy: links with the proteaso me. Curr Opin Cell Biol 2010, 22: 192-198.
99. Lee JY,Nagano Y,Taylor JP,Lim KL,Yao TP. Diseasecausing mutations in parkin impair mitochondrial ubiquitination, aggregation, and HDAC6- dependent mitophagy. J Cell Biol 2010, 189:671-679.
100. Wong E and Cuervo AM. Autophagy gone awry in neurodegenerative diseases. Nat Neurosci 2010, 13:805-811